UniQure, Syndax, Erasca Drawing Fresh Analyst Interest
Three clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
A straightforward rationale for incorporating Equal Weighted Indices into a portfolio, emphasizing diversification and simplicity.
22,501 articlesThree clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
A Hong Kong-based stablecoin payments processor plans a $150 million pre-IPO round to fuel a possible U.S. listing th...
Bitcoin briefly slips below the $80,000 level before rebounding, signaling a shallow pullback rather than a crash. On...
Investors are watching a pivotal Starship test as markets gauge the odds of a SpaceX IPO. A successful launch could s...
Planet Labs stock plummeting has investors weighing quarterly results against space-tech hype. This guide breaks down...
SpaceX began trading on Friday with a roughly $2 trillion market value after an IPO that stunned markets. The company...
The BIS warns that AI-driven hype could trigger a stock-market pullback and spill into credit markets, threatening gl...
Bitcoin has rebounded about 10% from a multi-year trough, but three on-chain signals must align before a sustained ra...
AI fears roiled tech names, dragging CrowdStrike lower despite strong fundamentals. Analysts see a 40% upside as sent...
Applied Optoelectronics and Lumentum jumped about 15% on Monday as a major hyperscale contract and index-driven buyin...
The Federal Reserve left rates unchanged and signaled a cautious path ahead, as inflation risks and geopolitical tens...
A hedge fund manager publicly admits that his temperament blocks Buffett-style value investing. The admission highlig...